Skip to main content
Veterinary Medicines

Frento Forte Flohschutztropfen 40 mg Lösung zum Auftropfen für kleine Katzen

Not authorised
  • Imidacloprid

Product identification

Medicine name:
Frento Forte Flohschutztropfen 40 mg Lösung zum Auftropfen für kleine Katzen
Advantage vet. 100 mg/ml påflekkingsvæske, oppløsning til katt
Active substance:
  • Imidacloprid
Target species:
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    40.00
    milligram(s)
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Authorisation status:
  • Surrendered
Authorised in:
  • Norway
Package description:
  • Pack sizes 0.4 ml solution per pipette, Pack containing 6 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 4 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 3 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 2 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 1 unit dose pipettes, Container: White polypropylene pipettes with caps

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 02-1091
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0021/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 1/06/2022